Betsabe Petra Carreño-Hinojosa retweeted
Precision technology is transforming how we care for patients with #prostatecancer.
Our own @dr_sprenkle and @YaleRadiology’s Jessica Lee, MD, explain how focal #ablation targets cancer while protecting quality of life ➡️ youtube.com/watch?v=BRT9nADx…
@YaleMed | @YaleMedicine
Betsabe Petra Carreño-Hinojosa retweeted
How many away rotations US MD students do varies sharply by intended specialty:
Ortho: 97% did ≥1; 3.4/student
ENT: 95%; 2.6
DR: 54%; 1.2
IM: 25%; 0.4
Betsabe Petra Carreño-Hinojosa retweeted
Applying in urology? The UrologyWatch Residency Program Navigator is live.
• All 150 programs on one page
• 2026–27 interview dates as programs post them, checked daily (43 so far)
• Tap a map to pick states and cities
• Filter by size, research time, call, VA, fellowships
Free. Share with your friends and students. #urologymatch
urologywatch.com/programs
Such a kind heart and so much dedication. Any program would be so lucky to have you, Sasha! 🫶🏻
Betsabe Petra Carreño-Hinojosa retweeted
Hi #medtwitter #UroSoMe!
My name is Ernesto and I’m an M4 applying into the urology match #match2027 from @WeillCornell and from @MSKCancerCenter as a research fellow.
Outside of the OR, you can find me watching Broadway shows, playing board games, and exploring NYC parks!
Betsabe Petra Carreño-Hinojosa retweeted
ERAS signed, sealed, and delivered✅
Hey #MedTwitter #UroSoMe! My name is Tae-Hee Kim, an MS4 from @OhioStateMed applying to Urology.
I’m passionate about mentorship, research, high value care, and my 2 cats 🐈⬛🐈
Excited to connect on the interview trail! #Match2027
Betsabe Petra Carreño-Hinojosa retweeted
So excited to share that I’m officially participating in the 2027 Match for General Surgery! 🥹 A lot of emotions, excitement, and happy nerves! Can’t wait to meet you all during interview season and hopefully find the program that feels like the perfect fit for me!
Betsabe Petra Carreño-Hinojosa retweeted
Your patient has had nephrectomy for high-risk clear cell RCC. The next decision: Surveillance, Pembrolizumab, or Pembrolizumab + belzutifan. Is adjuvant justified when surgery may already have been curative? Our new commentary explores this dilemma. 🧵bit.ly/4jkism6
Last weekend, I had the opportunity to present our work on active surveillance for small renal masses at the SCS of the AUA Annual Meeting in Tucson 🌵. Proud to share outcomes from our Latin American cohort and grateful to my mentors and the Urology team at INCMNSZ. 🇲🇽🩺
Betsabe Petra Carreño-Hinojosa retweeted
Excited to announce the appointment of Dr. Luis Medina as Associate Program Director of the Urologic Oncology Fellowship.
He joins our Program Director @MatveyTsivian in advancing our fellowship’s mission.
Congratulations @LuisMedinaMD !
@EMW2000 @SUO_YUO @JayChavaliMD @ResidentesCAU @muschollings @MUSC_Urology @AmerUrological @CAU_URO @UroOnc @Endo_Society
Betsabe Petra Carreño-Hinojosa retweeted
It’s time!!
Hi #MedTwitter
I’m Gabriela🇵🇷, a US-IMG 🇩🇴, former @Yale_Urology & current @CleClinicUro research fellow. Applying to this year’s Urology #Match2027
When free, I love to cook/bake, 🏋️♀️ and 🏃🏽♀️. Can’t wait to connect with everyone along the way!🤩 #UroSoMe @LatinXUro
Betsabe Petra Carreño-Hinojosa retweeted
Today is Chromophobe Kidney Cancer Day, a day to raise awareness of a rare subtype of renal cell carcinoma and recognize the patients, families, researchers, and advocates working to advance our understanding of the disease.
Chromophobe RCC accounts for only a small percentage of kidney cancer diagnoses, making dedicated research, education, and community especially important.
Learn more and connect with the community at coakidney.org/.
#AcceleratingCures
Betsabe Petra Carreño-Hinojosa retweeted
Top factors for urology residency match success include USMLE Step 1 scores above 230, research experiences, and AOA membership. Understanding these can guide applicants in assessing competitiveness and optimizing their applications. tinyurl.com/25d3qrx9
Betsabe Petra Carreño-Hinojosa retweeted
Sharing a new publication in @UrolOncol exploring key gaps in penile cancer care and where the field is headed—from patient advocacy and organ preservation to optimizing surgical management and emerging systemic therapy options.
Thanks to the entire team @SalvadorjcMD @f_eskenazi_MD @jpdugartemd @JadChahoud @SpiessPhilippe @GTumors
doi.org/10.1016/j.urolonc.20…
Betsabe Petra Carreño-Hinojosa retweeted
🚨 Results from #LITESPARK022 (#LS022) are out in @NEJM!
1/This phase III trial evaluated whether adding the HIF-2α inhibitor Belzutifan (BEL) to adjuvant pembrolizumab (PEMBRO) could improve outcomes for patients with resected clear-cell RCC at increased risk for recurrence.
nejm.org/doi/full/10.1056/NE…
@oncoalert @asco @myESMO
Some people leave a lasting impact on your journey. Dr. García-Mora @drgarciamora thank you for your mentorship, guidance, and for this incredible opportunity. This experience didn’t just strengthen my interest in urology, it showed me the kind of urologist I hope to become. 🫡
Some experiences stay with you long after they're over. Thanks to everyone at @PSH_Urology for making me feel welcome. I'm grateful for everything you taught me, the conversations we shared, and the friendships I made. I couldn't have asked for a better experience. 💙🫂
Betsabe Petra Carreño-Hinojosa retweeted
Congrats to all the @UroOnc matches today! A special shout out to our crew!
Betsabe Petra Carreño-Hinojosa retweeted
👏Huge congratulations to our residents, Blake Baer & @cassrabclark, on matching into their 2027 fellowships! Your hard work, dedication, & commitment to excellence have paid off. We are incredibly proud of all you have accomplished!
#FellowshipMatch #UrologyOnc #PSHUrology
My last AUA as a medical student and one I’ll always remember. Grateful to the Future in Urology program for the opportunity to learn from my mentor, Dr. Mark Tyson. @MarkTysonMD! Excited to keep learning and growing in urology. #AUA26 #urology
